Endoscopic sleeve gastroplasty, laparoscopic sleeve gastrectomy, and laparoscopic greater curve plication: do they differ at 2 years?

Abstract

Background Endoscopic sleeve gastroplasty (ESG) is an effective treatment option for obesity. However, data comparing its efficacy to bariatric surgery are scarce. We aimed to compare the effectiveness and safety of ESG with laparoscopic sleeve gastrectomy (LSG) and laparoscopic greater curve plication (LGCP) at 2 years.

Methods We reviewed 353 patient records and identified 296 patients who underwent ESG (n = 199), LSG (n = 61), and LGCP (n = 36) at four centers in Spain between 2014 and 2016. We compared their total body weight loss (%TBWL) and safety over 2 years. A linear mixed model (LMM) was used to analyze repeated measures of weight loss outcomes at 6, 12, 18, and 24 months to compare the three procedures.

Results Among the 296 patients, 210 (ESG 135, LSG 43, LGCP 32) completed 1 year of follow-up and 102 (ESG 46, LSG 34, LGCP 22) reached 2 years. Their mean (standard deviation [SD]) body mass index (BMI) was 39.6 (4.8) kg/m². There were no differences in age, sex, or BMI between the groups. In LMM analysis, adjusting for age, sex, and initial BMI, we found ESG had a significantly lower TBWL, %TBWL, and BMI decline compared with LSG and LGCP at all time points (P = 0.001). The adjusted mean %TBWL at 2 years for ESG, LSG, and LGCP were 18.5 %, 28.3 %, and 26.9 %, respectively. However, ESG, when compared with LSG and LGCP, had a shorter inpatient stay (1 vs. 3 vs. 3 days; P < 0.001) and lower complication rate (0.5 % vs. 4.9 % vs. 8.3 %; P = 0.006).

Conclusion All three procedures induced significant weight loss in obese patients. Although the weight loss was lower with ESG compared with other techniques, it displayed a better safety profile and shorter hospital stay.

^* Equal first authors

Publication History

Received: 25 February 2020

Accepted: 22 July 2020

Accepted Manuscript online:
22 July 2020

Article published online:
05 October 2020

• References

• 1 Ward ZJ, Bleich SN, Cradock AL. et al. Projected U.S. state-level prevalence of adult obesity and severe obesity. . NEJM 2019; 381: 2440-2450
• 2 Azagury D, Papasavas P, Hamdallah I. et al. ASMBS Position Statement on medium- and long-term durability of weight loss and diabetic outcomes after conventional stapled bariatric procedures. Surg Obes Relat Dis 2018; 14: 1425-1441
• 3 Baker MT. The history and evolution of bariatric surgical procedures. Surg Clin North Am 2011; 9: 1181-1201, viii
• 4 Carrano FM, Peev MP, Saunders JK. et al. The role of minimally invasive and endoscopic technologies in morbid obesity treatment: review and critical appraisal of the current clinical practice. Obes Surg 2020; 30: 736-752
• 5 Mechanick JI, Youdim A, Jones DB. et al. Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient–2013 update: cosponsored by American Association of Clinical Endocrinologists, the Obesity Society, and American Society for Metabolic & Bariatric Surgery. Surg Obes Relat Dis 2013; 9: 159-191
• 6 Angrisani L, Santonicola A, Iovino P. et al. IFSO Worldwide Survey 2016: primary, endoluminal, and revisional procedures. Obes Surg 2018; 28: 3783-3794
• 7 Himpens J, Ramos A, Welbourn R. et al. 4th IFSO Global Registry Report. 2018 Available at (Accessed 10 August 2020): https://www.ifso.com/pdf/4th-ifso-global-registry-report-last-2018.pdf
• 8 ASGE/ASMBS Task Force on endoscopic bariatric therapy. A pathway to endoscopic bariatric therapies. Surg Obes Relat Dis 2011; 7: 672-682
• 9 Lopez-Nava G, Sharaiha RZ, Vargas EJ. et al. Endoscopic sleeve gastroplasty for obesity: a multicenter study of 248 patients with 24 months follow-up. Obes Surg 2017; 27: 2649-2655
• 10 Alqahtani A, Al-Darwish A, Mahmoud AE. et al. Short-term outcomes of endoscopic sleeve gastroplasty in 1000 consecutive patients. Gastrointest Endosc 2019; 89: 1132-1138
• 11 Singh S, Hourneaux de Moura DT, Khan A. et al. Safety and efficacy of endoscopic sleeve gastroplasty worldwide for treatment of obesity: a systematic review and meta-analysis. Surg Obes Relat Dis 2020; 16: 340-351
• 12 Fiorillo C, Quero G, Vix M. et al. 6-month gastrointestinal quality of life (QoL) results after endoscopic sleeve gastroplasty and laparoscopic sleeve gastrectomy: a propensity score analysis. Obes Surg 2020; 30: 1944-1951
• 13 Lopez-Nava G, Asokkumar R, Lacruz T. et al. The effect of weight loss and exercise on health-related quality of life (HRQOL) following endoscopic bariatric therapies (EBT) for obesity. Health Qual Life Outcomes 2020; 18: 130
• 14 Fayad L, Cheskin LJ, Adam A. et al. Endoscopic sleeve gastroplasty versus intragastric balloon insertion: efficacy, durability, and safety. Endoscopy 2019; 51: 532-539
• 15 Cheskin LJ, Hill C, Adam A. et al. Endoscopic sleeve gastroplasty versus high-intensity diet and lifestyle therapy: a case-matched study. Gastrointest Endosc 2020; 91: 342-349.e1
• 16 Fayad L, Adam A, Schweitzer M. et al. Endoscopic sleeve gastroplasty versus laparoscopic sleeve gastrectomy: a case-matched study. Gastrointest Endosc 2019; 89: 782-788
• 17 Novikov AA, Afaneh C, Saumoy M. et al. Endoscopic sleeve gastroplasty, laparoscopic sleeve gastrectomy, and laparoscopic band for weight loss: how do they compare?. J Gastrointest Surg 2018; 22: 267-273
• 18 Lopez-Nava G, Galvão MP, Bautista-Castaño I. et al. Endoscopic sleeve gastroplasty: how I do it?. Obes Surg 2015; 25: 1534-1538
• 19 Aranceta BartrinaJ, Arija ValV. Grupo Colaborativo de la Sociedad Española de Nutrición Comunitaria (SENC). et al. Dietary guidelines for the Spanish population (SENC, December 2016); the new graphic icon of healthy nutrition. Nutr Hosp 2016; 33: 1-48
• 20 ASGE Bariatric Endoscopy Task Force and ASGE Technology Committee. ASGE Bariatric Endoscopy Task Force systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting endoscopic bariatric therapies. Gastrointest Endosc 2015; 82: 425-438.e5
• 21 García-García ML, Martín-Lorenzo JG, Lirón-Ruiz R. et al. Perioperative complications following bariatric surgery according to the clavien-dindo classification. Score validation, literature review and results in a single-centre series. . Surg Obes Relat Dis 2017; 13: 1555-1561
• 22 Saunders KH, Igel LI, Saumoy M. et al. Devices and endoscopic bariatric therapies for obesity. Curr Obes Rep 2018; 7: 162-171
• 23 James TW, Reddy S, Vulpis T. et al. Endoscopic sleeve gastroplasty is feasible, safe, and effective in a non-academic setting: short-term outcomes from a community gastroenterology practice. Obes Surg 2020; 30: 1404-1409
• 24 Mohan BP, Asokkumar R, Khan SR. et al. Outcomes of endoscopic sleeve gastroplasty; how does it compare to laparoscopic sleeve gastrectomy? A systematic review and meta-analysis. . Endosc Int Open 2020; 8: E558-E565
• 25 Hajifathalian K, Ang B, Dawod QM. et al. Long-term follow up and outcomes after endoscopic sleeve gastroplasty for treatment of obesity (5 year data). Gastrointest Endosc 2019; 89: AB58
• 26 Vargas EJ, Bazerbachi F, Calderon G. et al. Changes in time of gastric emptying after surgical and endoscopic bariatrics and weight loss: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 2020; 18: 57-68.e5
• 27 Abu Dayyeh B, Rizk M, El-Mohsen M. et al. Laparoscopic greater curvature plication (LGCP) vs endoscopic sleeve gastroplasty (ESG): similar efficacy with different physiology. Surg Obes Relat Dis 2017; 13: S205
• 28 Abu Dayyeh BK, Acosta A, Camilleri M. et al. Endoscopic sleeve gastroplasty alters gastric physiology and induces loss of body weight in obese individuals. Clin Gastroenterol Hepatol 2017; 15: 37-43.e1
• 29 Runge TM, Yang J, Fayad L. et al. Correction to: Anatomical configuration of the stomach post-endoscopic sleeve gastroplasty (ESG) – what are the sutures doing?. Obes Surg 2020; 30: 2061
• 30 Pizzicannella M, Lapergola A, Fiorillo C. et al. Does endoscopic sleeve gastroplasty stand the test of time? Objective assessment of endoscopic ESG appearance and its relation to weight loss in a large group of consecutive patients. Surg Endosc 2020; DOI: 10.1007/s00464-019-07329-1.
• 31 Kumbhari V, Lehmann S, Schlichting N. et al. Gastric mucosal devitalization is safe and effective in reducing body weight and visceral adiposity in a porcine model. Gastrointest Endosc 2018; 88: 175-184.e1
• 32 Lauti M, Kularatna M, Hill AG. et al. Weight regain following sleeve gastrectomy–a systematic review. Obes Surg 2016; 26: 1326-1334
• 33 Boškoski I, Pontecorvi V, Gallo C. et al. Redo endoscopic sleeve gastroplasty: technical aspects and short-term outcomes. Therap Adv Gastroenterol 2020; 13: 1756284819896179
• 34 Lopez-Nava G, Asokkumar R, Rull A. et al. Bariatric endoscopy procedure type or follow-up: What predicted success at 1 year in 962 obese patients?. Endosc Int Open 2019; 7: E1691-E1698
• 35 ASMBS Clinical Issues Committee. Updated position statement on sleeve gastrectomy as a bariatric procedure. Surg Obes Relat Dis 2012; 8: e21-e26
• 36 Peterli R, Wölnerhanssen BK, Peters T. et al. Effect of laparoscopic sleeve gastrectomy vs laparoscopic Roux-en-Y gastric bypass on weight loss in patients with morbid obesity: the SM-BOSS randomized clinical trial. JAMA 2018; 319: 255-265
• 37 Yeung KTD, Penney N, Ashrafian L. et al. Does sleeve gastrectomy expose the distal esophagus to severe reflux? a systematic review and meta-analysis. . Ann Surg 2020; 271: 257-265
• 38 Quero G, Fiorillo C, Dallemagne B. et al. The causes of gastroesophageal reflux after laparoscopic sleeve gastrectomy: quantitative assessment of the structure and function of the esophagogastric junction by magnetic resonance imaging and high-resolution manometry. Obes Surg 2020; 30: 2108-2117
• 39 Asokkumar R, Babu MP, Bautista I. et al. The use of the OverStitch for bariatric weight loss in Europe. Gastrointest Endosc Clin N Am 2020; 30: 129-145
• 40 Lopez-Nava G, Negi A, Bautista-Castaño I. et al. Gut and metabolic hormones changes after endoscopic sleeve gastroplasty (ESG) vs laparoscopic sleeve gastrectomy (LSG). . Obes Surg 2020; 30: 2642-2651